Bacterial sepsis is characterized by a rapid increase in the expression of inflammatory mediators to initiate the acute phase response in liver. Inflammatory mediator release is counterbalanced by the coordinated expression of anti-inflammatory molecules such as interleukin 1 receptor antagonist (IL1-Ra) through time. This study determined whether activation of pregnane X receptor (PXR, NR1I2) alters the lipopolysaccharide (LPS)-inducible gene expression program in primary cultures of hepatocytes (PCHs). Preactivation of PXR for 24 hours in PCHs isolated from wild-type mice suppressed the subsequent LPS-inducible expression of the key inflammatory mediators interleukin 1b (IL-1b), interleukin 6 (IL-6), and tumor necrosis factor a (TNFa) but not in PCHs isolated from Pxr-null (PXR-knockout [KO]) mice. Basal expression of key inflammatory cytokines was elevated in PCHs from PXR-KO mice. Stimulation of PCHs from PXR-KO mice with LPS alone produced enhanced levels of IL-1b when compared with wild-type mice. Experiments performed using PCHs from both humanized-PXR transgenic mice as well as human donors indicate that prolonged activation of PXR produces an increased secretion of IL1-Ra from cells through time. Our data reveal a working model that describes a pivotal role for PXR in both inhibiting as well as in resolving the inflammatory response in hepatocytes. Understanding the molecular details of how PXR is converted from a positive regulator of drug-metabolizing enzymes into a transcriptional suppressor of inflammation in liver will provide new pharmacologic strategies for modulating inflammatory-related diseases in the liver and intestine.Pregnane X receptor (PXR, NR1I2) is a ligand-activated nuclear receptor (NR) superfamily member expressed at high levels within the enterohepatic system of mammals. The biologic function of PXR is mediated together with its obligate partner retinoid X receptor a Lehmann et al., 1998). To date, the ligands identified for PXR have been numerous, and they are structurally diverse as naturally occurring steroids , antibiotics (Lehmann et al., 1998), bile acids (Staudinger et al., 2001a;Xie et al., 2001;Goodwin et al., 2003), anticancer agents (Desai et al., 2002;Nallani et al., 2004), and the active ingredients in several herbal remedies (Moore et al., 2000;Brobst et al., 2004;Ding and Staudinger, 2005). Ligand-activated PXR positively regulates the drug-inducible expression of genes encoding key drug transporters and drug metabolizing enzymes that function coordinately to increase the uptake, metabolism, excretion, and efflux of xenobiotics from the body. In this way, PXR activation is associated with increased metabolism and clearance of a myriad of potentially toxic compounds, and is classically thought of as a protective response.Clinical treatment with PXR activators can also lead to the repression or attenuation of other biochemical pathways in liver and intestine including both energy metabolism and the inflammatory response (Moreau et al., 2008). For example, it wa...